AUG 21, 2017 03:33 PM PDT
High-Doses of Vitamin C Stop Leukemia Cells From Multiplying
WRITTEN BY: Xuan Pham
3 19 693

Image credit: Pixabay.com

A new study reports that vitamin C has the capacity to stop leukemic cells from multiplying. The results are part of a growing list of evidence, which supports the anti-cancer properties of vitamin C.

Vitamin C has had a long stint with the medical community. In 1753, the compound was shown to ward off scurvy – a condition that was common among sailors at the time. Since then, vitamin C was purported to be effective against viruses like the common cold and the flu. More recently, the compound has been implicated as having cancer-fighting potential in cancer cells derived from the colon, brain, and blood.

In the current study, researchers at the Perlmutter Cancer Center at New York University (NYU) Langone Health focused on leukemia cells. Specifically, they were interested in an enzyme called Tet methylcytosine dioxygenase 2 (TET2), which signals stem cells to mature into differentiated blood cells. In various forms of leukemia, mutations in the TET2 gene contribute to an overabundance of immature blood stem cells and not enough of healthy white blood cells.

Researchers hope that by rescuing a malfunctioning copy of TET2, they can reverse leukemia. The team turned to vitamin C to test whether this compound could restore TET2 functions.

Indeed, intravenous injections of high-dose vitamin C seemed to rescue TET2 functions. The vitamin C compound is thought to engage in DNA demethylation - a process that signals blood stem cells to mature and die.

The researchers then combined vitamin C with a well-known class of anticancer drugs called PARP inhibitors. PARP inhibitors typically “cause cancer cell death by blocking the repair of DNA damage, and [are] already approved for treating certain patients with ovarian cancer,” explained Luisa Cimmino, the study’s lead author. In combination, the team report leukemia cells were less able to multiply and self-renew.

“Our work also suggests that vitamin C plus/minus PARP inhibitors might be part of a beneficial strategy for TET2 mutant [acute myeloid leukemia]," said Dr. Benjamin Neel, the study’s co-senior author.

The authors caution that these results are still preliminary and that further investigations in human clinical trials are necessary to reveal the full anti-cancer effects of vitamin C. In fact, a multi-center trial is being coordinated currently.

"We also plan additional preclinical studies to test the effects of high-dose vitamin C in combination with PARP [inhibitors] in more models of [acute myeloid leukemia] and in primary patient samples,” said Dr. Neel. "And finally, we plan experiments to identify other agents that might synergize with vitamin C in [acute myeloid leukemia] samples."

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
FEB 12, 2018
Cell & Molecular Biology
FEB 12, 2018
The Mechanism Linking Colon Cancer and High Cholesterol
Colon cancer rates are rising, especially among young people, and colorectal cancer is the second leading cause of death in the United States.
APR 04, 2018
Cancer
APR 04, 2018
Proposed New Genetic-Clinical Risk Grouping Model for Prostate Cancer
A group of researchers have proposed a new risk grouping model to more accurately/precisely predict the risk of prostate cancer progression though use of gene expression and clinical eval
APR 11, 2018
Cancer
APR 11, 2018
Breast Cancer Therapy Effects: Heart Damage and Mortality Risk Study Surprise Finding
Breast Cancer therapy has been demonstrated to cause side effects like damage to the heart; however, a new study published found that breast cancer survivor risk of death from heart disease f
MAY 01, 2018
Cancer
MAY 01, 2018
CNS Tumor Cells Destroyed by Zika Virus
CNS tumor classification changed in 2016 to incorporate tumor molecular markers. Researchers look at CNS tumor cells and destroy them with Zika virus infection
MAY 01, 2018
Cancer
MAY 01, 2018
The Microfluidic Device: Future Replacement for Bone Marrow Biopsy in Multiple Myeloma
Researchers have developed a microfluidic device that can detect circulating plasma cells in whole blood; therefore, negating the need for a bone marrow biopsy to diagnose Multiple Myeloma.
MAY 02, 2018
Cancer
MAY 02, 2018
Low Muscle Mass Could Be Affecting Breast Cancer Survival
Breast cancer patients that have low muscle mass were shown in a recent study to have higher mortality than patients with higher muscle mass at the time of diagnosis.
Loading Comments...